400-821-072
| 规格 | 目录价格 | 上海 | 安徽 | 武汉 | 成都 | 北方 | 深圳 | 会员价格 | 数量 |
|---|---|---|---|---|---|---|---|---|---|
| 1g | ￥ ǀŹĆŹŹ | > 10 | > 10 | 1 | -- | -- | -- | ￥ ǀŹĆŹŹ | - + |
| 10g | ￥ ǀǀĆŹŹ | 3 | > 10 | -- | -- | 1 | -- | ￥ ǀǀĆŹŹ | - + |
| 2g | ￥ ȃǕĆŹŹ | 1 | 7 | -- | 1 | 1 | 1 | ￥ ȃǕĆŹŹ | - + |
| 100g | ￥ ŜĪǕĆŹŹ | -- | 1 | -- | -- | 1 | -- | ￥ ŜĪǕĆŹŹ | - + |
| 00g | ￥ ðǦðĆŹŹ | -- | -- | -- | -- | -- | -- | ￥ ðǦðĆŹŹ | - + |
| 1000g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
| 大货 | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
10.31
[1]. Bergstrom JD, et al. Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase. Arch Biochem Biophys. 2000 Jan 1;373(1):231-41.
[2]. Elliott SN, et al. Alendronate induces gastric injury and delays ulcer healing in rodents. Life Sci. 1998;2(1):77-91.
[3]. Fisher JE, et al. Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro. Proc Natl Acad Sci U S A. 1999 Jan ;9(1):133-8
[4]. Keller RK, et al. Mechanism of aminobisphosphonate action: characterization of alendronate inhibition of the isoprenoid pathway. Biochem Biophys Res Commun. 1999 Dec 20;2(2):0-3.
[]. Stearns ME, et al. Effects of alendronate and taxol on PC-3 ML cell bone metastases in SCID mice. Invasion Metastasis. 199;1(3):11-31.
P24-P270-P01
沪ICP备170194号
